Rapid Respiratory Microbiological Point-of-Care Testing and Antibiotic Use in Primary Care: A Randomized - Summary - MDSpire

Rapid Respiratory Microbiological Point-of-Care Testing and Antibiotic Use in Primary Care: A Randomized

  • By

  • Alastair D. Hay

  • Samantha Abbs

  • Matthew Ridd

  • Stephen Granier

  • J. Athene Lane

  • Peter Muir

  • Jodi Taylor

  • Grace Young

  • Kathy Eastwood

  • Hayley Dash

  • Lynne Bradshaw

  • Rebecca Clarke

  • Mandy Lui

  • Emma Bridgeman

  • Rachel C. M. Brierley

  • Emily Brown

  • Hannah V. Thornton

  • Paul M. Mitchell

  • Liang Zhu

  • Lucy Yardley

  • Chris Metcalfe

  • July 1, 2026

  • 0 min

Share

Objective:

To evaluate the efficacy of a multiplex rapid microbiological point-of-care test (RM-POCT) in reducing same-day antibiotic prescribing for respiratory infections in primary care.

Approach:
  • Study Design: A controlled, parallel-group, randomized clinical trial conducted at 16 general practices in Southwest England.
  • Participants: Patients aged at least 12 months presenting with a clinician-diagnosed respiratory tract infection (RTI) within 21 days of onset.
  • Intervention: Participants were randomized to receive either RM-POCT results or usual care without RM-POCT before antibiotic treatment decisions.
  • Outcome Measures: Primary outcomes included antibiotic prescribing and patient-reported symptom severity on days 2 to 4 post-consultation.
Key Findings:
  • The study protocol received ethical approval and adhered to CONSORT guidelines.
  • Participants completed symptom diaries for up to 28 days and provided nasal and throat swabs for testing.
  • The RM-POCT tested for 23 respiratory microbes, including 19 viruses and 4 atypical bacteria.
Interpretation:

The study aims to investigate the role of RM-POCTs in antibiotic stewardship for respiratory infections.

Limitations:
  • Evidence for RM-POCT use in primary care is currently sparse, particularly for PCR-based testing.
  • Potential increase in demand for primary care appointments due to RM-POCT availability.
Conclusion:

This trial represents an important step in evaluating the impact of RM-POCT on antibiotic prescribing practices in primary care settings.

Original Source(s)

Related Content